
### [MONDO:0016643](http://purl.obolibrary.org/obo/MONDO_0016643)
**Label:** frontonasal dysplasia

**Subclasses:** [MONDO:0007636](http://purl.obolibrary.org/obo/MONDO_0007636) (Frontorhiny), [MONDO:0013268](http://purl.obolibrary.org/obo/MONDO_0013268) (frontonasal dysplasia with alopecia and genital anomaly), [MONDO:0010570](http://purl.obolibrary.org/obo/MONDO_0010570) (craniofrontonasal syndrome), [MONDO:0015464](http://purl.obolibrary.org/obo/MONDO_0015464) (craniofrontonasal dysplasia-Poland anomaly syndrome), [MONDO:0009247](http://purl.obolibrary.org/obo/MONDO_0009247) (Frontofacionasal dysplasia), [MONDO:0007780](http://purl.obolibrary.org/obo/MONDO_0007780) (hypertelorism, Teebi type), [MONDO:0013271](http://purl.obolibrary.org/obo/MONDO_0013271) (frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome), [MONDO:0011082](http://purl.obolibrary.org/obo/MONDO_0011082) (Oculoauriculofrontonasal syndrome), [MONDO:0007956](http://purl.obolibrary.org/obo/MONDO_0007956) (Pai syndrome), [MONDO:0011359](http://purl.obolibrary.org/obo/MONDO_0011359) (acromelic frontonasal dysostosis), 

**Mapped go classes:** [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003404](http://purl.obolibrary.org/obo/GO_0003404) (optic vesicle morphogenesis), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:1990402](http://purl.obolibrary.org/obo/GO_1990402) (embryonic liver development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0014031](http://purl.obolibrary.org/obo/GO_0014031) (mesenchymal cell development), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:2001222](http://purl.obolibrary.org/obo/GO_2001222) (regulation of neuron migration), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0031295](http://purl.obolibrary.org/obo/GO_0031295) (T cell costimulation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- Thing 52.79%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.63%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005181](http://purl.obolibrary.org/obo/GO_0005181) (obsolete glycopeptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005180](http://purl.obolibrary.org/obo/GO_0005180) (obsolete peptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005177](http://purl.obolibrary.org/obo/GO_0005177) (obsolete neuroligin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005162](http://purl.obolibrary.org/obo/GO_0005162) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005156](http://purl.obolibrary.org/obo/GO_0005156) (obsolete epidermal growth factor receptor inhibiting ligand activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005155](http://purl.obolibrary.org/obo/GO_0005155) (obsolete epidermal growth factor receptor activating ligand activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005120](http://purl.obolibrary.org/obo/GO_0005120) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005116](http://purl.obolibrary.org/obo/GO_0005116) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005108](http://purl.obolibrary.org/obo/GO_0005108) (obsolete transmembrane ephrin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005107](http://purl.obolibrary.org/obo/GO_0005107) (obsolete GPI-linked ephrin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005106](http://purl.obolibrary.org/obo/GO_0005106) (obsolete ephrin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005103](http://purl.obolibrary.org/obo/GO_0005103) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 37.99%


